Quest
The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.
In Brief This Week: Atsena, Papillon, City of Hope, Labcorp, Quest Diagnostics, Angle
News items for the week of Sept. 16, 2024.
Quest's Haystack Oncology, U of Montreal to Study Liquid Biopsy MRD Test in Colorectal Cancer
The partners will use Haystack's MRD test to assess treatment response and detect early relapse in colorectal cancer patients with liver metastasis.
Becton Dickinson, Quest Diagnostics Collaborate on CDx Development
The firms will develop, manufacture, and commercialize flow cytometry-based companion diagnostics for cancer and other diseases.
Despite Broad Carve-Outs, FDA Final Rule on LDTs Draws Critical Response From Lab Industry
The rule makes explicit that LDTs are subject to FDA oversight but provides for enforcement discretion across a broad range of tests.
Feb 8, 2024